lobbying_activities: 2432393

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2432393	59de80b6-139e-440e-a725-097d1fb869f7	Q1	KOUNTOUPES DENHAM CARR & REID, LLC	320918	CVS HEALTH	2020	first_quarter	PHA	General education about the pharmacy benefit manager/pharmacy industry, including spread pricing proposals and S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU)Act. Issues related to Risk Evaluation and Mitigation Strategies (REMS) program. S. 1895, Lower Health Case Costs Act; S.1227, The Prescription Pricing for the People Act of 2019. Issues related to H.R.748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including provisions relating to the drug supply chain.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2020-04-17T14:36:41.257000-04:00